Farther Finance Advisors’s NeuroOne Medical Technologies NMTC Stock Holding History

Farther Finance Advisors’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-417	Closed	-$2.06K	–	4369
2024 Q4	$2.06K	Hold	417	–	–	﹤0.01%	2987
2024 Q3	$2.48K	Buy	+417	New	+$2.09K	﹤0.01%	2918

Other funds holding NMTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Farther Finance Advisors's NMTC Position: Q1 2025 in Review

Farther Finance Advisors sold out of NeuroOne Medical Technologies (NMTC) in Q1 2025, closing a stake of 417 shares — an estimated $2.06K sold.

Farther Finance Advisors first reported a position in NMTC in Q3 2024 and held it in 2 quarters. The position peaked at $2.48K in Q3 2024. 18 funds tracked by Wall St. Rank hold NMTC as of Q1 2025.

Farther Finance Advisors reported no remaining NeuroOne Medical Technologies position as of Q1 2025 after selling out during the quarter.
Farther Finance Advisors sold 417 NeuroOne Medical Technologies shares in Q1 2025, an estimated $2.06K.
Farther Finance Advisors first reported a position in NeuroOne Medical Technologies in Q3 2024 and held it in 2 quarters.
Farther Finance Advisors's NeuroOne Medical Technologies position peaked at $2.48K in Q3 2024.
18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2025.

Based on Farther Finance Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.